Effect of human serum on the in vitro anti- HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio) thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding
- 22 June 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (12) , 2507-2512
- https://doi.org/10.1016/0006-2952(93)90232-l
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivativesAntiviral Research, 1992
- HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587Biochemical Pharmacology, 1992
- A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templatesAntiviral Research, 1991
- Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)Journal of Medicinal Chemistry, 1991
- A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding siteBiochemistry, 1991
- A new class of HIV-1 specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)Journal of Medicinal Chemistry, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineJournal of Medicinal Chemistry, 1989